Blue Jet Healthcare
653.30
-18.20(-2.71%)
Market Cap₹11,648.20 Cr
PE Ratio31.61
IndustryHealthcare
Company Performance:
1D-2.71%
1M-6.45%
6M-14.29%
1Y+27.39%
5Y+58.03%
View Company Insightsright
More news about Blue Jet Healthcare
22Jul 25
Blue Jet Healthcare Reports 141% Surge in Q1 Profit, Revenue More Than Doubles
Blue Jet Healthcare Limited, a specialty pharmaceutical manufacturer, reported impressive Q1 results. Profit soared 141% to ₹911.70 crore, while revenue more than doubled to ₹3,547.58 crore. EBITDA grew 173.3% to ₹1,210.00 crore, with margin improving to 34.1%. Growth was primarily driven by higher sales in Pharma Intermediates & API. Despite strong performance, shares fell 10% due to sequential decline in EBITDA and margins.
14May 25
Blue Jet Healthcare's Q4 Profit Soars to ₹1.1 Billion, Marking Significant Growth
Blue Jet Healthcare, a key player in the pharmaceutical sector, announced a significant increase in its fourth-quarter net profit. The company reported a net profit of ₹1.10 billion, up from ₹396.00 million in the same quarter last year, representing a year-over-year growth of 177.78%. This substantial profit growth demonstrates the company's strong financial performance and could potentially impact its market position and investor confidence positively.
09Apr 25
Blue Jet Healthcare Expands into Chemical Intermediate Exports for Contrast Media Production
Blue Jet Healthcare has begun exporting a key chemical intermediate for gadolinium-based contrast media production in Q4FY25. This initiative is part of a collaboration with a European innovator partner. While not directly handling gadolinium, the company is now indirectly involved in the contrast media market, potentially opening new revenue streams. This move signifies Blue Jet's strategy to diversify its product portfolio and expand its global presence in the pharmaceutical ingredients market.
Blue Jet Healthcare
653.30
-18.20
(-2.71%)
1 Year Returns:+27.39%
Industry Peers
Sun Pharmaceutical
1,679.10
(+1.21%)
Divis Laboratories
6,621.50
(+0.32%)
Cipla
1,577.60
(+0.52%)
Torrent Pharmaceuticals
3,584.30
(+1.43%)
Dr Reddys Laboratories
1,255.90
(+1.27%)
Mankind Pharma
2,476.60
(+0.87%)
Zydus Life Science
987.65
(+0.31%)
Lupin
1,940.00
(-0.57%)
Alkem Laboratories
5,581.50
(+1.04%)
Aurobindo Pharma
1,101.00
(-0.48%)